CG CHONDROGENE Trademark

Trademark Overview


On Wednesday, December 31, 2003, a trademark application was filed for CG CHONDROGENE with the United States Patent and Trademark Office. The USPTO has given the CG CHONDROGENE trademark a serial number of 76568022. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 26, 2016. This trademark is owned by ChondroGene Limited. The CG CHONDROGENE trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

(Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for medical research and development use; (Based on on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for research use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for research use

(Based on 44(e)) Diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical laboratory use; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for clinical or medical use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for clinical or medical use; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies, and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts a...

(Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research

(Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors
cg chondrogene

General Information


Serial Number76568022
Word MarkCG CHONDROGENE
Filing DateWednesday, December 31, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 26, 2016
Registration Number3656206
Registration DateTuesday, July 21, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 7, 2008

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services(Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for medical research and development use; (Based on on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for research use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for research use
Goods and Services(Based on 44(e)) Diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical laboratory use; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for clinical or medical use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for clinical or medical use; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies, and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use
Goods and Services(Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research
Goods and Services(Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 26, 2016
Primary Code001
First Use Anywhere DateTuesday, January 7, 2003
First Use In Commerce DateTuesday, January 7, 2003

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 26, 2016
Primary Code042
First Use Anywhere DateMonday, November 18, 2002
First Use In Commerce DateMonday, November 18, 2002

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 26, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENENEWS LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond Hill Ontario L
CA

Party NameGENENEWS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond Hill Ontario L
CA

Party NameGENENEWS LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressRichmond Hill Ontario L
CA

Party NameChondroGene Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressToronto, Ontario M3J 3K4
CA

Trademark Events


Event DateEvent Description
Friday, February 26, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, July 21, 2009REGISTERED-PRINCIPAL REGISTER
Wednesday, June 17, 20091(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, June 16, 2009NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 17, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 16, 2009TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 30, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2008NOTICE OF PUBLICATION
Thursday, September 4, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 28, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 28, 2008EXAMINERS AMENDMENT MAILED
Wednesday, August 27, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, August 27, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, August 14, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 13, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 18, 2008NON-FINAL ACTION MAILED
Tuesday, June 17, 2008NON-FINAL ACTION WRITTEN
Monday, May 5, 2008PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, April 28, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, April 11, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 10, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 8, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 8, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 8, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 9, 2007NON-FINAL ACTION MAILED
Thursday, November 8, 2007NON-FINAL ACTION WRITTEN
Thursday, October 18, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, October 5, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, September 21, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 20, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 20, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 19, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, September 12, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 22, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 6, 2007PAPER RECEIVED
Thursday, March 29, 2007PRIORITY ACTION MAILED
Wednesday, March 28, 2007PRIORITY ACTION WRITTEN
Monday, February 12, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, February 5, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, January 14, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 12, 2007AMENDMENT FROM APPLICANT ENTERED
Friday, January 12, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 12, 2007ASSIGNED TO LIE
Monday, December 11, 2006PAPER RECEIVED
Monday, October 23, 2006LETTER OF SUSPENSION MAILED
Friday, October 20, 2006SUSPENSION LETTER WRITTEN
Friday, October 13, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, September 5, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 5, 2006PAPER RECEIVED
Tuesday, June 20, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 13, 2006INQUIRY AS TO SUSPENSION MAILED
Sunday, March 12, 2006SUSPENSION INQUIRY WRITTEN
Monday, September 12, 2005LETTER OF SUSPENSION MAILED
Friday, September 9, 2005SUSPENSION LETTER WRITTEN
Friday, September 9, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 16, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2005PAPER RECEIVED
Wednesday, March 23, 2005LETTER OF SUSPENSION MAILED
Wednesday, March 23, 2005SUSPENSION LETTER WRITTEN
Wednesday, March 23, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, March 14, 2005LETTER OF SUSPENSION MAILED
Sunday, March 13, 2005SUSPENSION LETTER WRITTEN
Wednesday, February 23, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, January 31, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 31, 2005PAPER RECEIVED
Monday, August 2, 2004NON-FINAL ACTION MAILED
Tuesday, July 20, 2004ASSIGNED TO EXAMINER
Wednesday, January 14, 2004NEW APPLICATION ENTERED IN TRAM